Results 51 to 60 of about 6,183,390 (300)

Vaccines for COVID-19 [PDF]

open access: yesClinical and Experimental Immunology, 2020
SummarySince the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019, there has been an explosion of vaccine development. By 24 September 2020, a staggering number of vaccines (more than 200) had started preclinical development, of which 43 had entered clinical trials, including some approaches that have not previously been ...
Tregoning, J. S.   +9 more
openaire   +3 more sources

The characteristic and clinical profiles among COVID-19 patients at the National Emergency Hospital Wisma Atlet Jakarta in 2021

open access: yesJurnal Cakrawala Promkes, 2022
The World Health Organization designated Covid-19, caused by SARS-COV-2, a worldwide pandemic on March 11, 2020, and it has been entering Indonesia since early March 2020.
Misriani Misriani   +11 more
doaj   +1 more source

Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

open access: yes, 2022
BACKGROUND: The effectiveness of fluvoxamine to shorten symptom duration or prevent hospitalization among outpatients in the US with mild to moderate symptomatic coronavirus disease 2019 (COVID-19) is unclear. DESIGN: ACTIV-6 is an ongoing, decentralized,
Boulware, David R.   +27 more
core   +1 more source

Allergy and COVID-19.

open access: yesActa bio-medica : Atenei Parmensis, 2021
The first cases of as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in Wuhan, China in December 2019. The World Health Organization declared the global pandemic in March 2020. Coronavirus disease 2019 (COVID-19) showed high rates of mortality in the adult population, whereas a mild course was observed in ...
De Filippo M.   +11 more
openaire   +5 more sources

The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa

open access: yesBMC Public Health, 2023
Objective In this study, we investigated the impact of COVID-19 NPIs in South Africa to understand their effectiveness in the reduction of transmission of COVID-19 in the South African population.
Thabo Mabuka   +6 more
doaj   +1 more source

COVID-19 and tuberculosis [PDF]

open access: yesJournal of Translational Internal Medicine, 2020
Abstract On March 11, 2020, the WHO declared that coronavirus disease 2019 (COVID-19) can be characterized as a pandemic based on the alarming levels of spread and severity and on the alarming levels of inaction. COVID-19 has received worldwide attention as emergency, endangering international public health and economic development ...
Yang, Heng, Lu, Shuihua
openaire   +2 more sources

ANALYSIS EXPOSURE INDEX AS AN OPTIMIZATION EFFORT ON EXAMINATION CHEST POSTERIOR ANTERIOR

open access: yesJournal of Vocational Health Studies, 2020
Background: Radiographers are responsible for producing image quality which can provide accurate diagnostic information by considering the lowest possible radiation dose according to the As Low As Reasonably Achievable (ALARA) principle.
Muhammad Irsal   +6 more
doaj   +1 more source

Surgical treatment of tension pneumomediastinum in patients with covid-19 at the field hospital: a case series

open access: yesJournal of Cardiothoracic Surgery, 2022
Background Tension pneumomediastinum is one of the most serious complications in COVID-19 patients with respiratory distress requiring invasive mechanical ventilation.
Phan Quang Thuan   +4 more
doaj   +1 more source

Bloodstream Infections in a COVID-19 Non-ICU Department: Microbial Epidemiology, Resistance Profiles and Comparative Analysis of Risk Factors and Patients’ Outcome

open access: yesMicroorganisms, 2022
Background: Bloodstream infections (BSI) caused by highly resistant pathogens in non-ICU COVID-19 departments pose important challenges. Methods: We performed a comparative analysis of incidence and microbial epidemiology of BSI in COVID-19 vs. non-COVID-
Efthymia Giannitsioti   +19 more
doaj   +1 more source

Case Report: Successful Treatment of a Child With COVID-19 Reinfection-Induced Fulminant Myocarditis by Cytokine-Adsorbing oXiris® Hemofilter Continuous Veno-Venous Hemofiltration and Extracorporeal Membrane Oxygenation

open access: yesFrontiers in Pediatrics, 2022
BackgroundIndirect cardiomyocyte damage-related hyperinflammatory response is one of the key mechanisms in COVID-19-induced fulminant myocarditis. In addition to the clinical benefit of using cytokines absorption hemofiltration, the effectiveness of ...
Phuc H. Phan   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy